The subtype-specific effects of droperidol on action potential duration in cellular and computational models of long QT syndrome.
Related Research units
Abstract
Droperidol is a highly potent butyrophenone used for the therapy of postoperative nausea and vomiting. Its cardiac safety in cardiovascular-healthy patients and those with long QT (LQT) syndrome is a matter of debate. In this study, we investigated whether droperidol has subtype-specific effects in cellular and computational models of LQT syndrome.
Bibliographical data
| Original language | German |
|---|---|
| Article number | 3 |
| ISSN | 0003-2999 |
| Publication status | Published - 2010 |
| pubmed | 20601449 |
|---|
